Lawyers representing more than 70 bereaved families have urged the Lampard inquiry into mental health deaths in Essex to recommend a nationwide ban on Oxevision, an infrared camera monitoring system used in approximately half of England’s mental health wards.
The families contend that the surveillance technology has contributed materially to patient harms and deaths. The inquiry heard that five patients died by suicide or unexpected circumstances while under Oxevision monitoring at Essex Partnership University NHS foundation trust over a two-year period. Legal representatives argued that the system has frequently been used as a substitute for direct staff observation, preventing critical therapeutic engagement and opportunities for intervention. They further stated that claims about the system’s effectiveness by its manufacturer, Oxford-based company Lio, lack scientific support, with the inquiry’s own statisticians finding no evidence to substantiate such assertions.
Beyond safety concerns, attorneys highlighted privacy and psychological impacts. Legal counsel characterized the camera technology as creating a coercive power imbalance and noted that the intrusive nature of bedroom surveillance may increase patient paranoia and anxiety. Expert evidence presented to the inquiry suggested the cameras can prompt distressed reactions from patients. The inquiry chair is considering issuing interim recommendations, potentially including suspension of the system if deemed necessary to prevent further deaths.
Manufacturer representatives contested the characterization, stating that only four of approximately 2,000 deaths examined occurred while Oxevision was in use, with none attributed to the technology itself. They maintained that implementation failures by trusts, rather than the system’s design, were responsible for negative outcomes and that proper operation has enabled staff to identify institutional failings. They argued the technology assists in critical safety interventions and that it complements rather than replaces clinical care.
Separately, the information commissioner has launched a data protection investigation into Oxevision.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI